Recombinant APP (Donanemab Biosimilar) 抗体
Research Grade
适用: 人
ELISA, WB
宿主: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- 抗原
- APP (Donanemab Biosimilar)
- 抗体类型
- Recombinant Antibody
- 适用
- 人
- 宿主
-
Mammalian Cells
- Expression System
- Mammalian cells
- 克隆类型
- 单克隆
- 应用范围
- ELISA, Western Blotting (WB)
- 原理
- Donanemab Biosimilar - Anti-APP mAb
- 产品特性
- Antibody Type: IgG1-kappa
- 纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
- 质量等级
- Research Grade
- 亚型
- IgG1 kappa
-
- 限制
- 仅限研究用
-
- 缓冲液
- PBS buffer pH 7.5
- 储存条件
- -80 °C
- 储存方法
- store at -80°C
-
- 抗原
- APP (Donanemab Biosimilar)
- 物质类
- Biosimilar
- 背景
-
LY3002813
Donanemab is a humanized IgG1 monoclonal antibody directed at an N‐terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research.
-
You are here:
